HE's making the same progress as DCVax Prostate.
To give you an idea what I mean, go use the Internet Archive to go back and check the NWBO website to see how long that's been pending either a trial start or a partnership!
But seriously, NWBO does not seem to need or care about HE and its cousin in the UK and I can guess why:
A year ago, Ms. Powers still needed to use HE and EAMS to make retail investors believe revenue and public recognition for NWBO was right around the corner.
Now that Woodford and other big fish are investing, she doesn't need to trick us retail investors into sticking with a good investment anymore.
Thus, just like DCVax Prostate, HE and EAMS have outlived their usefulness and will be effectively though never officially abandoned.
By the time HE gets going (if it ever does) NWBO will be done with Phase 3 and we won't need it anyway.
Maybe I'm wrong about HE, and if I am, given the number of NWBO shares I hold, I won't be eating crow, I'll be eating foie gras.
But either way, giving up on HE reimbursement has made me a lot less frustrated as an NWBO investor and is helping me to sit back and enjoy the ride.
News 
Market Data 
Discover 
AI
